Recent work has continued to challenge and expand our views on the neural control of body weight. Leptin receptors have been shown to engage multiple signaling pathways in a neuron-specific pattern. The overall goals of our proposal are to decipher the crosstalk between the cAMP/PKA signaling system and the leptin receptor-initiated signals in neuronal pathways that regulate feeding and energy expenditure. Mouse genetic techniques allow us to investigate this problem in a physiological setting and also provide us with novel tools for defining regulation at the molecular level. We propose to use our newly developed ribosome-tagging approaches (RiboTag) to quantitate the translatome (mRNAs actively engaged on polyribosomes) in specific subtypes of hypothalamic neurons. Our focus will be on those groups of neurons that respond to the adipocyte-synthesized hormone, leptin, and also express the RIIb regulatory subunit of PKA. The RIIb-PKA KO mouse line is lean and resistant to diet-induced obesity and our recent results indicate that this is because of an increase in leptin sensitivity in the hypothalamus.
The specific aims of this proposal are: (1) Analyze the regulation of mRNA expression/translation in specific hypothalamic cell types by diet and hormones (2) Identify the nutritional regulators of PKA activation in the hypothalamus (3) Develop a strategy to increase the sensitivity of hypothalamic neurons to leptin by pharmacological regulation of the cAMP/PKA pathway. At the conclusion of these studies we will have completed a comprehensive analysis of mRNA transcripts in key hypothalamic neuronal populations as they respond to nutritional signals. We also expect to gain a better understanding of the mechanisms by which PKA activity can modulate leptin signaling and adiposity. The sensitivity of the hypothalamic response network to leptin is one of the ultimate determinants of how much energy an organism will store as fat. The cAMP/PKA system is well suited to pharmacological manipulation by agonists and antagonists of G-protein coupled receptors, phosphodiesterase inhibitors, and kinase activators and inhibitors. Our proposal seeks to identify potential targets within hypothalamic neurons that might be exploited to modulate leptin sensitivity as a therapeutic approach to the treatment of obesity.

Public Health Relevance

The combination of high caloric diets and lack of exercise leads to obesity and greatly increases the risk of adult onset diabetes, hypertension, and other adverse cardiovascular problems. Using a mouse model we have discovered a mutation in the cAMP/PKA signaling system that enhances the response of the brain to a hormone, leptin that is produced in fat cells and tells us to stop eating and increase metabolism. Mice with this mutation are resistant to diet-induced obesity and our proposal will study the mechanism of this protective effect with the goal of developing a therapy that will induce resistance to diet-induced obesity in humans.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Dunsmore, Sarah
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Yang, Linghai; Gilbert, Merle L; Zheng, Ruimao et al. (2014) Selective expression of a dominant-negative type I? PKA regulatory subunit in striatal medium spiny neurons impairs gene expression and leads to reduced feeding and locomotor activity. J Neurosci 34:4896-904
Wu, Qi; Zheng, Ruimao; Srisai, Dollada et al. (2013) NR2B subunit of the NMDA glutamate receptor regulates appetite in the parabrachial nucleus. Proc Natl Acad Sci U S A 110:14765-70
Zheng, Ruimao; Yang, Linghai; Sikorski, Maria A et al. (2013) Deficiency of the RII? subunit of PKA affects locomotor activity and energy homeostasis in distinct neuronal populations. Proc Natl Acad Sci U S A 110:E1631-40
Lu, Yuan; Zha, Xiang-ming; Kim, Eun Young et al. (2011) A kinase anchor protein 150 (AKAP150)-associated protein kinase A limits dendritic spine density. J Biol Chem 286:26496-506
Willis, Brandon S; Niswender, Colleen M; Su, Thomas et al. (2011) Cell-type specific expression of a dominant negative PKA mutation in mice. PLoS One 6:e18772
Nagalla, Srikanth; Shaw, Chad; Kong, Xianguo et al. (2011) Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117:5189-97
Weisenhaus, Michael; Allen, Margaret L; Yang, Linghai et al. (2010) Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice. PLoS One 5:e10325
Nichols, C Blake; Rossow, Charles F; Navedo, Manuel F et al. (2010) Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 107:747-56
Sanz, Elisenda; Yang, Linghai; Su, Thomas et al. (2009) Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc Natl Acad Sci U S A 106:13939-44
Lu, Yuan; Zhang, Mingxu; Lim, Indra A et al. (2008) AKAP150-anchored PKA activity is important for LTD during its induction phase. J Physiol 586:4155-64

Showing the most recent 10 out of 70 publications